← Leaderboards
Jessica Diane Lang
Translational Genomics Research Inst
$967,346
Attributed
$967,346
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $248.8K · FY2019–23$250K$187.5K$125K$62.5K$0
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$967,346 · 2
By mechanism
R00$744,490 · 1
K99$222,856 · 1
Top collaborators
No co-investigators on record.
Most similar at Translational Genomics Research Inst
Same institution · by research overlap
- Matt Huentelman$25,001,101
- Yashar Kalani$905,174
- Kendall R Van Keuren-Jensen$3,951,101
- Robert Spetzler$166,667
Others in their field
Other Emerging Leaders on “Enhancers”
- Chanza Baytop · Westat, Inc.$271,217,917
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- John E West · University Of Texas At Austin$95,166,667
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$90,963,700
- Peter K Fritschel · California Institute Of Technology$78,820,000
Research focus
EnhancersEpigenetic ProcessCrispr InterferenceDrug TargetingAwardAdvisory CommitteesClinical CareAnimalsDevelopment PlansDiagnosticCancer PatientCancer SubtypesCancer TherapyCancer TypeBioinformaticsChip-SeqCareer DevelopmentCell LineBromodomainDecision MakingCell ProliferationAcetylationChemotherapyEquipment
Grant awards (6)
Characterization of the role of super-enhancers in ovarian cancer treatment response$246,961
R00 · FY2023 · CA · contact PI
Characterization of the role of super-enhancers in ovarian cancer treatment response$248,734
R00 · FY2022 · CA · contact PI
Characterization of the role of super-enhancers in ovarian cancer treatment response$248,795
R00 · FY2021 · CA · contact PI
Characterization of the role of super-enhancers in ovarian cancer treatment response$84,428
K99 · FY2020 · CA · contact PI
Characterization of the role of super-enhancers in ovarian cancer treatment response$54,000
K99 · FY2020 · CA · contact PI
Characterization of the role of super-enhancers in ovarian cancer treatment response$84,428
K99 · FY2019 · CA · contact PI